IDF general

IDF

UN Summit Outcomes Document

To influence the political leaders of the world, IDF and the NCD Alliance have released a Proposed Outcomes Document that outlines the goals and targets that should be agreed upon at the close of the High-Level UN Summit.

IDF is now embarking on a critical period of the Summit journey and this document will mark the beginning of an important dialogue which will help IDF persuade world leaders to combat cancer, cardiovascular disease, chronic respiratory disease and diabetes.

Calling the world to action on diabetes: an advocacy toolkit

The clock is ticking down to the UN High-Level Summit on Non-Communicable Diseases (NCDs). In less than six months, world leaders will gather in New York for a meeting that has the potential to change the world for the millions of people living with diabetes, cancer, cardiovascular disease and chronic respiratory disease. This Summit offers an unrivalled opportunity to broker commitments at the highest level and create a sustained global movement on NCDs.

Contact us

Why partner with IDF

With 387 million people living with diabetes today and 592 million expected to have diabetes by 2030, the global diabetes epidemic represents one of the major health and development challenges of the 21st century. Four out of five people with diabetes live in developing countries. Be part of the solution and join the fight against diabetes!

2011

2011 - Q2 newsletter - EN, ES, FR


Message de la directrice générale

« FID : créer un effet d’entraînement en faveur de la lutte contre le diabète »

Cinq questions à…

Parlez-nous un peu de vous.

Profil d’un champion

Nom : Phil Southerland

Titre : Directeur de la formation cycliste Team Type 1, tout dernier membre des Champions du Cercle bleu de la FID et acteur de premier plan dans la lutte contre le diabète.

Quête ultime : Modifier la situation mondiale du diabète.

Cinco preguntas con…

Cuéntenos un poco sobre usted.
Mi nombre es Juan José Gagliardino. Soy Doctor en Medicina y Profesor de Psicología en la Escuela de Medicina de la Universidad Nacional de La Plata en Argentina. También soy investigador del Consejo Nacional de Investigación de Argentina y Director de CENEXA, Centro de Endocrinología Experimental y Aplicada (UNLP-CONICET La Plata, Centro Colaborador PAHO/WHO).

Mensaje de la Directora Ejecutiva

“FID: creando un efecto dominó en la promoción de la diabetes”

Pages